글로벌 황반모세혈관확장증 치료 시장 - 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 황반 모세혈관확장증 치료 시장

황반 모세혈관확장증 치료 시장은 2021-2028년 예측 기간에 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간에 6.7%의 CAGR로 성장할 것으로 예측하여 시장을 분석합니다.

황반변성은 눈 의 황반이라고 불리는 부분에 영향을 미치는 드문 신경퇴행성 안구 질환입니다 . 황반의 변성은 물체를 명확하게 보는 데 필요한 선명하고 중앙의 시력을 제공하기 때문에 중앙 시력을 잃게 됩니다. 황반 주위의 모세혈관이 확장되어 누출될 때 발생합니다. 이로 인해 빛의 반사를 방해하고 점진적인 시력 상실을 유발하는 체액이 축적됩니다. 주로 50~60세의 사람들에게 영향을 미칩니다. 이 질환은 야맹증, 터널 비전 및 중앙 시력 상실이 특징입니다. 특발성 황반 주변 망막 모세혈관확장증이라고도 합니다.

안구 표면 손상의 발생률 증가는 신경영양성 각막염에 기여할 수 있기 때문이며, 진보된 치료법의 개발은 시장 성장에 영향을 미치는 주요 요인입니다. 또한, 새로운 개입의 개발을 위한 연구자에 대한 막대한 재정 지원, 규제 당국에 대한 특별 지정 증가, 시력을 개선할 수 있는 세포 치료법 의 발전 은 황반 모세혈관확장증 치료 시장을 확대할 요인입니다.

새로운 치료법에 대한 수요 증가와 연구 개발 활동에 대한 막대한 투자는 2021~2028년 예측 기간 동안 황반부 모세혈관확장증 치료 시장에 유익한 기회를 제공할 것입니다.

그러나 개발도상국의 낮은 의료 예산과 치료와 관련된 높은 비용은 시장 성장을 방해하는 요인입니다. 수술적 치료는 눈의 모양과 기능을 변화시킬 수 있으며, 위에서 언급한 예측 기간 동안 황반 모세혈관확장증 치료 시장에 도전할 것입니다.

This Macular telangiectasia treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the Macular telangiectasia treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Macular Telangiectasia Treatment Market Scope and Market Size

The Macular telangiectasia treatment market is segmented on the basis of type, treatment, drugs, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of type, the Macular telangiectasia treatment market is segmented into type 1 macular telangiectasia and type 2 macular telangiectasia.
• On the basis of treatment, the Macular telangiectasia treatment market is segmented into drugs and surgery. Drugs have been further sub-segmented into ranibizumab, fluocinolone acetonide and others. Surgery has been further sub-segmented into vitreoretinal surgery and subretinal surgery.
• On the basis of route of administration, the Macular telangiectasia treatment market is segmented into oral, topical and others.
• On the basis of end-users, the Macular telangiectasia treatment market is segmented into hospitals, homecare, specialty clinics, ophthalmic clinic and others.
• The Macular telangiectasia treatment market is also segmented on the basis of distribution channel into hospital pharmacies, retail pharmacies and online pharmacies.

Macular Telangiectasia Treatment Market Country Level Analysis

Macular telangiectasia treatment market is analyzed and market size information is provided by the country, therapy type, treatment type, drugs, route of administration, end-users and distribution channel as referenced above.

The countries covered in the Macular telangiectasia treatment market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the Macular telangiectasia treatment market due to the rise in the prevalence of eye disorders, favourable reimbursement policies, high healthcare expenditure, and increasing geriatric population in this region. Asia-Pacific is expected to grow during the forecast period of 2021-2028 due to the increasing research and development activities, growing awareness, surge in the investment for healthcare sector and increase in the disposable income.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Macular telangiectasia treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Macular Telangiectasia Treatment Market Share Analysis

Macular telangiectasia treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to Macular telangiectasia treatment market research.

황반성 모세혈관확장증 치료 시장 보고서에 포함된 주요 기업으로는 Alcon Vision LLC, Neurotech, BioInvent International AB, Oxurion NV, Alcon, Allergan, F. Hoffmann-La Roche Ltd, The Emmes Company, LLC, Sun Pharmaceutical Industries Ltd, Lupin, Glenmark Pharmaceuticals Limited, Perrigo Company plc, Nimble Pharmaceuticals, Encube Ethicals, Glasshouse Pharmaceuticals, Akorn, Incorporated Lyne Laboratories, Teva Pharmaceutical Industries Ltd 등이 있으며, 국내 및 글로벌 기업도 있습니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-47885